<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="165">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on August 12, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04497415</url>
  </required_header>
  <id_info>
    <org_study_id>8032</org_study_id>
    <nct_id>NCT04497415</nct_id>
  </id_info>
  <brief_title>The COVID-19 and Healthcare Workers: An Active Intervention</brief_title>
  <official_title>The COVID-19 and Healthcare Workers: An Active Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Research Foundation for Mental Hygiene, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Research Foundation for Mental Hygiene, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overarching goal of this study is to examine the efficacy of a brief video intervention&#xD;
      in reducing stigma and fear, and improving help-seeking behavior, among health care providers&#xD;
      (N=1,200), with pre- post- and follow-up assessments (at day 14 and day 30). Participants&#xD;
      will be recruited via Amazon Turk and randomly assigned to either a) a video-based&#xD;
      intervention (day 1 and a &quot;booster intervention&quot; of the same content on day 14 of the study)&#xD;
      featuring the personal story of a health care provider during COVID-19 pandemic, his/her&#xD;
      struggles and barriers to care, (b) video-based intervention (day 1 only), and a written&#xD;
      description of the same story on day 14 (c) no-intervention control arm (questionnaires&#xD;
      only).&#xD;
&#xD;
      The invetsigators aim to (1) determine whether video-based intervention reduce stigma and&#xD;
      fear, and increase help-seeking behavior in relation to COVID-19 among health care providers,&#xD;
      and (2) compare high-risk areas (e.g., NY) to low-risk areas (e.g., Montana) on intervention&#xD;
      outcomes, and (3) test whether symptoms of depression, anxiety, PTSD and Moral Injury&#xD;
      (measured by the Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder (GAD-7),&#xD;
      the Primary Care PTSD Screen for DSM-5 (PC-PTSD-5) and the Moral Injury Events Scale (MIES))&#xD;
      would change over time.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coronavirus disease 2019 (COVID-19) has widely and rapidly spread around the world. To&#xD;
      effectively respond to the COVID-19 outbreak, various governments have implemented rapid and&#xD;
      comprehensive public health emergency interventions that include social restrictions and&#xD;
      quarantines, which is the separation and restriction of movement of people who might have&#xD;
      been exposed to the virus. While the physical risk (e.g. pneumonia, respiratory breakdown) is&#xD;
      getting the most scientific and clinical attention, this outbreak also has significant mental&#xD;
      health risks and extreme psychological fear-related responses. Psychological responses to&#xD;
      previous large-scale outbreaks, particularly to the Ebola Virus Disease (EVD) epidemic during&#xD;
      2014-2016, provide insight into the potential impact of rapidly spreading diseases on mental&#xD;
      health problems. During the Ebola outbreak, fear-related behaviors such as stigmatizing&#xD;
      infected survivors and ignoring medical procedures impeded public health efforts and&#xD;
      negatively affected the recovery of survivors. Anxiety, posttraumatic stress disorder (PTSD),&#xD;
      and depression were found in nearly half of the EVD survivors and their contacts.&#xD;
&#xD;
      The COVID-19 outbreak exceeds the scope and magnitude of most previous disasters over the&#xD;
      last 100 years. It entails a blend of risk factors for both acute and long-term mental health&#xD;
      problems. Data that is started to emerge from the COVID-19 outbreak, suggest that front lines&#xD;
      health workers (doctors; nurses) are particularly at risk. A recent study in 1257 health care&#xD;
      workers from 34 hospitals, conducted between January 29 to February 3, 2020, revealed that&#xD;
      more than half (50.4%) of the health workers were screened positive for depression, 44.6% for&#xD;
      anxiety, and 34.0% for insomnia. Consistent with previous disaster studies a dose-response&#xD;
      relationship was found between the level of exposure and outcomes. Others may develop a moral&#xD;
      injury, profound psychological distress which results in actions, or the lack of them, which&#xD;
      violet one's moral or ethical code. Given the magnitude of the COVID-19 outbreak, its risk to&#xD;
      physical and mental health, an effective and timely response is essential to address the&#xD;
      psychosocial needs associated with the ongoing exposure to disease, death, and distress among&#xD;
      health care providers, across low and high risks areas.&#xD;
&#xD;
      Many health care providers reluctant to seek support from friends and family, as well as&#xD;
      mental health care due to stigma and fear (e.g., &quot;it would be too embarrassing&quot;, &quot;I would be&#xD;
      seen as week&quot;). Despite enduring symptoms, they may wait months to years before they seek&#xD;
      help. Among reasons to avoid seeking mental health care, individuals report mistrust in&#xD;
      mental health providers, being seen as weak or stereotyped as &quot;crazy&quot;, and a belief that they&#xD;
      may be responsible for having mental health problems. Applying strategies to reduce stigma&#xD;
      and fear towards mental health care and improve help-seeking behavior may ameliorate impaired&#xD;
      functioning and reduce risks for long-term psychiatric illness.&#xD;
&#xD;
      Previous studies have shown that social contact is the most effective type of intervention to&#xD;
      reduce stigma- related attitudes and to improve help-seeking behavior. Social contact&#xD;
      involves interpersonal contact with members of the stigmatized group: members of the general&#xD;
      public who meet and interact with individuals who suffer from stress, fear, depression, or&#xD;
      anxiety and seek mental health care, are likely to lessen their stigma. Corrigan has&#xD;
      identified the most important ingredients of contact-based programs: an empowered presenter&#xD;
      with lived experience who attains his/her goals (e.g., &quot;I was able to fight the&#xD;
      depression/distress that I had following the COVID-19&quot;). While both direct, in-person social&#xD;
      contact and indirect, video-based social contact have effectively improved attitudes toward&#xD;
      mental issues and care, the latter can be implemented on a larger scale, use a minimal&#xD;
      resource and easily disseminated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 21, 2020</start_date>
  <completion_date type="Actual">January 30, 2021</completion_date>
  <primary_completion_date type="Actual">November 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Help-seeking Behavior</measure>
    <time_frame>Assessed at baseline and post-intervention (both day 1), first follow-up (day 14), and second follow-up (day 30)</time_frame>
    <description>Measured with the Attitudes Towards Seeking Professional Psychological Help Scale (ATSPPH) - total scores range from 3 to 12, with higher scores indicating greater treatment-seeking intentions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Generalized Anxiety Disorder-7 (GAD-7)</measure>
    <time_frame>Assessed at baseline, 14-day follow-up, and 30-day follow-up</time_frame>
    <description>Measured with the GAD-7 scale - total scores range from 0 to 21, with higher scores indicating greater self-reported anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patient Health Questionnaire-9 (PHQ-9)</measure>
    <time_frame>Assessed at baseline, 14-day follow-up, and 30-day follow-up</time_frame>
    <description>Measured with PHQ-9 - total scores range from 0 to 27; higher scores indicate greater self-reported depression</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Care Posttraumatic Stress Disorder (PC-PTSD) Screen</measure>
    <time_frame>Assessed at baseline, 14-day follow-up, and 30-day follow-up</time_frame>
    <description>Measured with the PC-PTSD for DSM-5 - total scores range from 0 to 5, with higher scores indicating greater self-reported PTSD symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Moral Injury Events Scale (MIES)</measure>
    <time_frame>Assessed at baseline, 14-day follow-up, and 30-day follow-up</time_frame>
    <description>Measured with the MIES - scores range from 9 to 36, with higher scores indicating greater moral injury</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">350</enrollment>
  <condition>Brief Video-based Intervention</condition>
  <condition>Non Intervention Control</condition>
  <arm_group>
    <arm_group_label>Video-based intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A brief video about coping with COVID-19 stress presented to the participants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Assessment only</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Video-Based intervention</intervention_name>
    <description>Three minutes video of a nurse that shares her personal story</description>
    <arm_group_label>Video-based intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        English speakers Healthcare workers aged 18-80 and residents of the USA.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Non-English speakers, non-healthcare workers, age less than 18 or more than 80, non-US&#xD;
        residents&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuval Neria, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University and NYSPI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York State Psychiatric Institute</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2022</verification_date>
  <study_first_submitted>August 2, 2020</study_first_submitted>
  <study_first_submitted_qc>August 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2020</study_first_posted>
  <results_first_submitted>December 24, 2021</results_first_submitted>
  <results_first_submitted_qc>December 24, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">January 11, 2022</results_first_posted>
  <last_update_submitted>January 12, 2022</last_update_submitted>
  <last_update_submitted_qc>January 12, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Research Foundation for Mental Hygiene, Inc.</investigator_affiliation>
    <investigator_full_name>Yuval Y Neria</investigator_full_name>
    <investigator_title>Professor of medical psychology</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 20, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/15/NCT04497415/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Video-based Intervention</title>
          <description>A brief video about coping with COVID-19 stress presented to the participants&#xD;
Video-Based intervention: Three minutes video of a nurse that shares her personal story</description>
        </group>
        <group group_id="P2">
          <title>Assessment Only</title>
          <description>Control</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="229"/>
                <participants group_id="P2" count="121"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Post-intervention Assessment (Day 1)</title>
              <participants_list>
                <participants group_id="P1" count="229"/>
                <participants group_id="P2" count="121"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>First Follow-up Assessment (Day 14)</title>
              <participants_list>
                <participants group_id="P1" count="195"/>
                <participants group_id="P2" count="102"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="186"/>
                <participants group_id="P2" count="94"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Video-based Intervention</title>
          <description>A brief video about coping with COVID-19 stress presented to the participants&#xD;
Video-Based intervention: Three minutes video of a nurse that shares her personal story</description>
        </group>
        <group group_id="B2">
          <title>Assessment Only</title>
          <description>Control</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="229"/>
            <count group_id="B2" value="121"/>
            <count group_id="B3" value="350"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.3" spread="11.5"/>
                    <measurement group_id="B2" value="33.8" spread="11.5"/>
                    <measurement group_id="B3" value="34.8" spread="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="165"/>
                    <measurement group_id="B2" value="95"/>
                    <measurement group_id="B3" value="260"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="201"/>
                    <measurement group_id="B2" value="115"/>
                    <measurement group_id="B3" value="316"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="170"/>
                    <measurement group_id="B2" value="86"/>
                    <measurement group_id="B3" value="256"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="229"/>
                    <measurement group_id="B2" value="121"/>
                    <measurement group_id="B3" value="350"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Occupation</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Nurse</title>
                  <measurement_list>
                    <measurement group_id="B1" value="156"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="237"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Physician</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
                <category>
                  <title>EMT</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Exposure to COVID-19</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Help-seeking Behavior</title>
        <description>Measured with the Attitudes Towards Seeking Professional Psychological Help Scale (ATSPPH) - total scores range from 3 to 12, with higher scores indicating greater treatment-seeking intentions</description>
        <time_frame>Assessed at baseline and post-intervention (both day 1), first follow-up (day 14), and second follow-up (day 30)</time_frame>
        <population>Fifty-three participants were lost to follow-up before first follow-up (day 14) and 70 were lost to follow-up before second follow-up (day 30).</population>
        <group_list>
          <group group_id="O1">
            <title>Video-based Intervention</title>
            <description>A brief video about coping with COVID-19 stress presented to the participants&#xD;
Video-Based intervention: Three minutes video of a nurse that shares her personal story</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>Control</description>
          </group>
        </group_list>
        <measure>
          <title>Help-seeking Behavior</title>
          <description>Measured with the Attitudes Towards Seeking Professional Psychological Help Scale (ATSPPH) - total scores range from 3 to 12, with higher scores indicating greater treatment-seeking intentions</description>
          <population>Fifty-three participants were lost to follow-up before first follow-up (day 14) and 70 were lost to follow-up before second follow-up (day 30).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="229"/>
                    <count group_id="O2" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2" lower_limit="7.9" upper_limit="8.5"/>
                    <measurement group_id="O2" value="8.5" lower_limit="8.1" upper_limit="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Post-intervention</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="229"/>
                    <count group_id="O2" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.3" lower_limit="9.0" upper_limit="9.6"/>
                    <measurement group_id="O2" value="8.7" lower_limit="8.2" upper_limit="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>First follow-up (day 14)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="195"/>
                    <count group_id="O2" value="102"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.7" lower_limit="9.4" upper_limit="10.0"/>
                    <measurement group_id="O2" value="9.3" lower_limit="8.9" upper_limit="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Second follow-up (day 30)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="94"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4" lower_limit="9.1" upper_limit="9.7"/>
                    <measurement group_id="O2" value="9.1" lower_limit="8.8" upper_limit="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Generalized Anxiety Disorder-7 (GAD-7)</title>
        <description>Measured with the GAD-7 scale - total scores range from 0 to 21, with higher scores indicating greater self-reported anxiety</description>
        <time_frame>Assessed at baseline, 14-day follow-up, and 30-day follow-up</time_frame>
        <population>Fifty-three participants were lost to follow-up before first follow-up (day 14) and 70 were lost to follow-up before second follow-up (day 30).</population>
        <group_list>
          <group group_id="O1">
            <title>Video-based Intervention</title>
            <description>A brief video about coping with COVID-19 stress presented to the participants&#xD;
Video-Based intervention: Three minutes video of a nurse that shares her personal story</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>Control</description>
          </group>
        </group_list>
        <measure>
          <title>Generalized Anxiety Disorder-7 (GAD-7)</title>
          <description>Measured with the GAD-7 scale - total scores range from 0 to 21, with higher scores indicating greater self-reported anxiety</description>
          <population>Fifty-three participants were lost to follow-up before first follow-up (day 14) and 70 were lost to follow-up before second follow-up (day 30).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (day 1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="229"/>
                    <count group_id="O2" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.6" spread="5.9"/>
                    <measurement group_id="O2" value="6.7" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>First follow-up (day 14)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="195"/>
                    <count group_id="O2" value="102"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" spread="6.0"/>
                    <measurement group_id="O2" value="5.9" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Second follow-up (day 30)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="94"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" spread="5.7"/>
                    <measurement group_id="O2" value="5.4" spread="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Patient Health Questionnaire-9 (PHQ-9)</title>
        <description>Measured with PHQ-9 - total scores range from 0 to 27; higher scores indicate greater self-reported depression</description>
        <time_frame>Assessed at baseline, 14-day follow-up, and 30-day follow-up</time_frame>
        <population>Fifty-three participants were lost to follow-up before first follow-up (day 14) and 70 were lost to follow-up before second follow-up (day 30).</population>
        <group_list>
          <group group_id="O1">
            <title>Video-based Intervention</title>
            <description>A brief video about coping with COVID-19 stress presented to the participants&#xD;
Video-Based intervention: Three minutes video of a nurse that shares her personal story</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>Control</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Health Questionnaire-9 (PHQ-9)</title>
          <description>Measured with PHQ-9 - total scores range from 0 to 27; higher scores indicate greater self-reported depression</description>
          <population>Fifty-three participants were lost to follow-up before first follow-up (day 14) and 70 were lost to follow-up before second follow-up (day 30).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (day 1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="229"/>
                    <count group_id="O2" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9" spread="6.6"/>
                    <measurement group_id="O2" value="6.6" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>First follow-up (day 14)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="195"/>
                    <count group_id="O2" value="102"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread="6.7"/>
                    <measurement group_id="O2" value="6.0" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Second follow-up (day 30)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="94"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.0" spread="6.2"/>
                    <measurement group_id="O2" value="5.4" spread="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Primary Care Posttraumatic Stress Disorder (PC-PTSD) Screen</title>
        <description>Measured with the PC-PTSD for DSM-5 - total scores range from 0 to 5, with higher scores indicating greater self-reported PTSD symptoms</description>
        <time_frame>Assessed at baseline, 14-day follow-up, and 30-day follow-up</time_frame>
        <population>Fifty-three participants were lost to follow-up before first follow-up (day 14) and 70 were lost to follow-up before second follow-up (day 30).</population>
        <group_list>
          <group group_id="O1">
            <title>Video-based Intervention</title>
            <description>A brief video about coping with COVID-19 stress presented to the participants&#xD;
Video-Based intervention: Three minutes video of a nurse that shares her personal story</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>Control</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Care Posttraumatic Stress Disorder (PC-PTSD) Screen</title>
          <description>Measured with the PC-PTSD for DSM-5 - total scores range from 0 to 5, with higher scores indicating greater self-reported PTSD symptoms</description>
          <population>Fifty-three participants were lost to follow-up before first follow-up (day 14) and 70 were lost to follow-up before second follow-up (day 30).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (day 1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="229"/>
                    <count group_id="O2" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="1.6"/>
                    <measurement group_id="O2" value="1.8" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>First follow-up (day 14)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="195"/>
                    <count group_id="O2" value="102"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="1.6"/>
                    <measurement group_id="O2" value="1.2" spread="1.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Second follow-up (day 30)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="94"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="1.7"/>
                    <measurement group_id="O2" value="1.4" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Moral Injury Events Scale (MIES)</title>
        <description>Measured with the MIES - scores range from 9 to 36, with higher scores indicating greater moral injury</description>
        <time_frame>Assessed at baseline, 14-day follow-up, and 30-day follow-up</time_frame>
        <population>Fifty-three participants were lost to follow-up before first follow-up (day 14) and 70 were lost to follow-up before second follow-up (day 30).</population>
        <group_list>
          <group group_id="O1">
            <title>Video-based Intervention</title>
            <description>A brief video about coping with COVID-19 stress presented to the participants&#xD;
Video-Based intervention: Three minutes video of a nurse that shares her personal story</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>Control</description>
          </group>
        </group_list>
        <measure>
          <title>Moral Injury Events Scale (MIES)</title>
          <description>Measured with the MIES - scores range from 9 to 36, with higher scores indicating greater moral injury</description>
          <population>Fifty-three participants were lost to follow-up before first follow-up (day 14) and 70 were lost to follow-up before second follow-up (day 30).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="229"/>
                <count group_id="O2" value="121"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (day 1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="229"/>
                    <count group_id="O2" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.1" spread="6.4"/>
                    <measurement group_id="O2" value="17.1" spread="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>First follow-up (day 14)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="195"/>
                    <count group_id="O2" value="102"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.1" spread="6.8"/>
                    <measurement group_id="O2" value="16.5" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Second follow-up (day 30)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="186"/>
                    <count group_id="O2" value="94"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.5" spread="6.7"/>
                    <measurement group_id="O2" value="16.5" spread="6.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days</time_frame>
      <desc>Our definition of adverse event and serious adverse event does not differ from the clinicaltrials.gov definition.</desc>
      <group_list>
        <group group_id="E1">
          <title>Video-based Intervention</title>
          <description>A brief video about coping with COVID-19 stress presented to the participants&#xD;
Video-Based intervention: Three minutes video of a nurse that shares her personal story</description>
        </group>
        <group group_id="E2">
          <title>Assessment Only</title>
          <description>Control</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="229"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="121"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="229"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="121"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="229"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="121"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Yuval Y. Neria</name_or_title>
      <organization>New York State Psychiatric Institute</organization>
      <phone>646-774-8092</phone>
      <email>ny126@cumc.columbia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

